ecNumber*2.3.1.78#specificActivity*-999#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*487500#!ecNumber*2.3.1.78#specificActivity*-999#specificActivityMaximum*#commentary*Sanfilippo syndrome type C patients in comparison#organism*Homo sapiens#literature*487507#!ecNumber*2.3.1.78#specificActivity*-999#specificActivityMaximum*#commentary*mutant A489E, relative activity 23.1%, wild-type 100%; mutant A615T, relative activity 54.9%, wild-type 100%; mutant C76F, relative activity 15.4%, wild-type 100%; mutant D562V, relative activity 22.0%, wild-type 100%; mutant E471K, relative activity 19.8%, wild-type 100%; mutant G262R, relative activity 17.6%, wild-type 100%; mutant G424S, relative activity 18.7%, wild-type 100%; mutant K523Q, relative activity 96.7%, wild-type 100%; mutant L137P, relative activity 17.6%, wild-type 100%; mutant M482K, relative activity 24.2%, wild-type 100%; mutant N273K, relative activity 18.7%, wild-type 100%; mutant P237Q, relative activity 108.8%, wild-type 100%; mutant P283L, relative activity 20.9%, wild-type 100%; mutant P571L, relative activity 22.0%, wild-type 100%; mutant R344C, relative activity 12.1%, wild-type 100%; mutant R344H, relative activity 14.3%, wild-type 100%; mutant S518F, relative activity 30.8%, wild-type 100%; mutant S539C, relative activity 27.5%, wild-type 100%; mutant S541L, relative activity 23.1%, wild-type 100%; mutant V481L, relative activity 114.3%, wild-type 100%; mutant W403C, relative activity 17.6%, wild-type 100%#organism*Homo sapiens#literature*706441#!ecNumber*2.3.1.78#specificActivity*0.000017#specificActivityMaximum*#commentary*leukocyte, substrate 4-methylumbelliferyl-alpha-D-glucosaminide + acetyl-CoA#organism*Homo sapiens#literature*487507#!ecNumber*2.3.1.78#specificActivity*0.000022#specificActivityMaximum*#commentary*leukocyte, substrate 4-methylumbelliferyl-beta-D-glucosaminide + acetyl-CoA#organism*Homo sapiens#literature*487507#!ecNumber*2.3.1.78#specificActivity*0.000058#specificActivityMaximum*#commentary*fibroblast, substrate 4-methylumbelliferyl-beta-D-glucosaminide + acetyl-CoA#organism*Homo sapiens#literature*487507#!ecNumber*2.3.1.78#specificActivity*0.000059#specificActivityMaximum*#commentary*fibroblast, substrate 4-methylumbelliferyl-alpha-D-glucosaminide + acetyl-CoA#organism*Homo sapiens#literature*487507#!ecNumber*2.3.1.78#specificActivity*0.000673#specificActivityMaximum*#commentary*lysosomal fraction#organism*Homo sapiens#literature*487506#!ecNumber*2.3.1.78#specificActivity*0.008#specificActivityMaximum*#commentary*#organism*Rattus norvegicus#literature*487501#!ecNumber*2.3.1.78#specificActivity*0.34#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*676018#!ecNumber*2.3.1.78#specificActivity*5.351#specificActivityMaximum*#commentary*#organism*Homo sapiens#literature*676018#